Treasurer of the State of North Carolina’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$838K Buy
57,527
+7,520
+15% +$133K ﹤0.01% 1049
2026
Q1
$948K Buy
50,007
+1,067
+2% +$17.3K ﹤0.01% 946
2025
Q4
$856K Sell
48,940
-3,579
-7% -$67.3K ﹤0.01% 964
2025
Q3
$1.08M Sell
52,519
-2,041
-4% -$49.5K ﹤0.01% 965
2025
Q2
$1.16M Buy
+54,560
New +$1.24M ﹤0.01% 972

Other funds holding SMMT

Treasurer of the State of North Carolina's SMMT Position: Q2 2026 in Review

Treasurer of the State of North Carolina increased its Summit Therapeutics (SMMT) stake by 15% in Q2 2026, buying an estimated $133K and bringing the position to 57,527 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Treasurer of the State of North Carolina first reported a position in SMMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.16M in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Treasurer of the State of North Carolina held 57,527 shares of Summit Therapeutics worth $838K as of Q2 2026.
  • Treasurer of the State of North Carolina bought 7,520 Summit Therapeutics shares in Q2 2026, an estimated $133K.
  • Summit Therapeutics made up ﹤0.01% of Treasurer of the State of North Carolina's portfolio in Q2 2026, its #1049 holding.
  • Treasurer of the State of North Carolina first reported a position in Summit Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Treasurer of the State of North Carolina's Summit Therapeutics position peaked at $1.16M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.